Wow – these are the AI sources worth paying attention to
Isomorphic Labs has raised $2.1 billion to advance AI-driven drug discovery, building on AlphaFold's protein structure prediction breakthroughs. Researchers have developed an AI model capable of solving Olympiad-level math and science problems using advanced training techniques. OpenAI has integrated Codex into ChatGPT, enabling remote Mac control from iPhones and consolidating its product teams under a unified strategy.
- ▪Isomorphic Labs, founded by Demis Hassabis, raised $2.1 billion to accelerate AI-based drug discovery using AlphaFold technology.
- ▪A new AI model trained with reverse perplexity curriculum and reinforcement learning achieved gold-medal performance in international math and physics Olympiads.
- ▪OpenAI integrated Codex into the ChatGPT app, allowing users to remotely control Mac devices from their iPhones.
- ▪X platform open-sourced its 'For You' recommendation algorithm on GitHub, promoting transparency in social media ranking systems.
- ▪OpenAI merged ChatGPT, Codex, and its developer API into a single product team led by Greg Brockman to unify its consumer and developer offerings.
Opening excerpt (first ~120 words) tap to expand
☰ FAV0 May 16, 2026 · Saturday Isomorphic Labs raises $2.1B to accelerate AI drug discovery Google DeepMind co-founder Demis Hassabis founded Isomorphic Labs completes $2.1 billion funding round for AI protein structure prediction and molecular design. Isomorphic Labs builds on AlphaFold breakthroughs to design novel molecules and shorten drug development timelines. Isomorphic Labs, the AI-first drug discovery company founded by Google DeepMind co-founder Demis Hassabis, has raised $2.1 billion in new funding. The company builds on DeepMind's groundbreaking AlphaFold protein structure prediction technology to design novel therapeutic molecules and dramatically shorten the drug development timeline.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Fav0.